A researcher from Scripps Florida has for the first time shown a link between low levels of a specific hormone and increased risk of metabolic disease in humans – an important step forward for scientists' understanding of factors that can lead to coronary artery disease, stroke, and type 2 diabetes.
The study, led by Dr. Andrew Butler, an associate professor at The Scripps Research Institute (TSRI), and a national team of researchers, focuses on the hormone adropin. Adropin, which Dr. Butler identified during a previous study, is believed to play an important role in regulating glucose levels and fatty acid metabolism.
No comments:
Post a Comment